ES2061996T3 - Regiones no esenciales de avipoxvirus. - Google Patents
Regiones no esenciales de avipoxvirus.Info
- Publication number
- ES2061996T3 ES2061996T3 ES89306326T ES89306326T ES2061996T3 ES 2061996 T3 ES2061996 T3 ES 2061996T3 ES 89306326 T ES89306326 T ES 89306326T ES 89306326 T ES89306326 T ES 89306326T ES 2061996 T3 ES2061996 T3 ES 2061996T3
- Authority
- ES
- Spain
- Prior art keywords
- fpv
- viruses
- dna
- vaccine
- avipoxviruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
- 238000005215 recombination Methods 0.000 abstract 1
- 208000006379 syphilis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA INVENCION SE REFIERE A DNA DE VIRUS DE SIFILIS AVIAR (FPV), PROPORCIONANDO UNA REGION NO ESENCIAL PARA LA INSERCION DE GENES EXTRAÑOS EN EL, Y DE AHI LA CONSTRUCCION DE UN VECTOR PARA RECOMBINACION HOMOLOGA CON UN FPV TIPO SILVESTRE, CON LO QUE EL FPV RECOMBINANTE QUE RESULTA SE PUEDE UTILIZAR PARA VACUNAR ANIMALES, ESPECIALMENTE GALLINAS. EN ESTA INVENCION, LA REGION NO ESENCIAL CONSTA ESENCIALMENTE DE UN CORTE DE DNA DE LA SECUENCIA UNICA LARGA DE LA REPITICION INVERTIDA TERMINAL (TIR) DE FPV O DE LA REGION EN LA QUE EL FPV CORRESPONDE APROXIMADAMENTE A LOS GENES D8 Y D9 DEL FRAGMENTO D DE HIND III EN VIRUS DE VACUNAS.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888815098A GB8815098D0 (en) | 1988-06-24 | 1988-06-24 | Fowlpox virus non-essential regions |
GB898904411A GB8904411D0 (en) | 1989-02-27 | 1989-02-27 | Fowlpox virus non-essential regions(2) |
GB898907374A GB8907374D0 (en) | 1989-03-31 | 1989-03-31 | Fowlpox virus non-essential regions(3) |
GB898910520A GB8910520D0 (en) | 1989-05-08 | 1989-05-08 | Fowlpox virus non-essential regions(4) |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061996T3 true ES2061996T3 (es) | 1994-12-16 |
Family
ID=27450125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89306326T Expired - Lifetime ES2061996T3 (es) | 1988-06-24 | 1989-06-22 | Regiones no esenciales de avipoxvirus. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5310671A (es) |
EP (1) | EP0353851B1 (es) |
JP (1) | JP2538367B2 (es) |
AU (1) | AU623913B2 (es) |
DE (1) | DE68912441T2 (es) |
DK (1) | DK304390A (es) |
ES (1) | ES2061996T3 (es) |
GB (1) | GB2220941B (es) |
PT (1) | PT90967B (es) |
WO (1) | WO1989012684A1 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US7045313B1 (en) | 1982-11-30 | 2006-05-16 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA |
DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
DE3813093A1 (de) * | 1988-04-19 | 1989-11-09 | Immuno Ag | Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung |
US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
AU623476B2 (en) * | 1988-12-29 | 1992-05-14 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
JP3044062B2 (ja) * | 1989-03-08 | 2000-05-22 | ヘルス・リサーチ・インク | 組換えポックスウイルス宿主選択系 |
US5759552A (en) * | 1991-03-07 | 1998-06-02 | Virogenetics Corporation | Marek's disease virus recombinant poxvirus vaccine |
BE1004877A3 (fr) * | 1991-05-27 | 1993-02-16 | Solvay | Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus. |
US5369025A (en) * | 1991-06-28 | 1994-11-29 | The United States Of America As Represented By The Secretary Of Agriculture | Recombinant fowlpox vaccine for protection against Marek's disease |
AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
EP0597016A4 (en) * | 1991-07-26 | 1996-04-24 | Virogenetics Corp | Infectious bursal disease virus recombinant poxvirus vaccine. |
EP0538496B1 (en) * | 1991-08-26 | 2003-10-29 | Baxter Healthcare S.A. | Recombinant fowlpox virus with intact FPV-tk-gene |
FR2682966B1 (fr) * | 1991-10-29 | 1994-12-02 | Rhone Merieux | Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
US5443831A (en) * | 1991-10-29 | 1995-08-22 | University Of Delaware | Gene encoding glycoprotein B of Infectious Laryngotracheitis Virus |
US6127163A (en) * | 1992-01-13 | 2000-10-03 | Syntro Corporation | Recombinant swinepox virus |
US5869312A (en) * | 1992-01-13 | 1999-02-09 | Syntro Corporation | Recombinant swinepox virus |
US6251403B1 (en) | 1992-01-13 | 2001-06-26 | Syntro Corporation | Recombinant swinepox virus |
US6033904A (en) * | 1992-01-13 | 2000-03-07 | Syntro Corporation | Recombinant swinepox virus |
US6497882B1 (en) | 1992-01-13 | 2002-12-24 | Syntro Corporation | Recombinant swinepox virus |
US6328975B1 (en) | 1992-01-13 | 2001-12-11 | Syntro Corporation | Recombinant swinepox virus |
PT623172E (pt) * | 1992-01-13 | 2005-02-28 | Virogenetics Corp | Vacina de virus vaccinia recombinante do virus da doenca de marek |
US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
EP0696204A4 (en) * | 1993-02-26 | 1999-03-31 | Syntro Corp | Recombined chickenpox virus and its use |
US6875856B2 (en) | 1993-09-24 | 2005-04-05 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
WO1995008622A1 (en) * | 1993-09-24 | 1995-03-30 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
US5882856A (en) * | 1995-06-07 | 1999-03-16 | Genzyme Corporation | Universal primer sequence for multiplex DNA amplification |
FR2757061B1 (fr) * | 1996-12-16 | 1999-03-26 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
US6335185B1 (en) | 1998-02-03 | 2002-01-01 | University Technologies International Inc. | Bacteriophage vectors generated by bacteriophage/plasmid recombination |
AU5446700A (en) * | 1999-05-28 | 2000-12-18 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
EP1694852B1 (en) | 2003-11-17 | 2010-10-13 | Crusade Laboratories Limited | Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
GB0326798D0 (en) | 2003-11-17 | 2003-12-24 | Crusade Lab Ltd | Methods for generating mutant virus |
US7897146B2 (en) | 2003-11-17 | 2011-03-01 | Crusade Laboratories Limited | Treatment using herpes simplex virus |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
EP0084416B1 (en) * | 1982-01-18 | 1986-09-03 | Stephen David Mills | Stopper support mechanism for casting containers |
EP0190254A4 (en) * | 1984-07-05 | 1987-03-09 | Genex Corp | GENE CLONE AND PROCESS FOR THE PREPARATION AND USE THEREOF. |
WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
EP0284416B1 (en) * | 1987-03-27 | 1995-02-22 | Nippon Zeon Co., Ltd. | Recombinant avipoxyvirus |
DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
CA1340203C (en) * | 1987-09-16 | 1998-12-15 | Noboru Yanagida | Recombinant apivoxvirus |
FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
AU623476B2 (en) * | 1988-12-29 | 1992-05-14 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
-
1989
- 1989-06-22 GB GB8914306A patent/GB2220941B/en not_active Expired - Fee Related
- 1989-06-22 JP JP1507253A patent/JP2538367B2/ja not_active Expired - Lifetime
- 1989-06-22 US US07/613,565 patent/US5310671A/en not_active Expired - Fee Related
- 1989-06-22 ES ES89306326T patent/ES2061996T3/es not_active Expired - Lifetime
- 1989-06-22 DE DE89306326T patent/DE68912441T2/de not_active Expired - Fee Related
- 1989-06-22 EP EP89306326A patent/EP0353851B1/en not_active Expired - Lifetime
- 1989-06-22 AU AU38537/89A patent/AU623913B2/en not_active Ceased
- 1989-06-22 WO PCT/GB1989/000698 patent/WO1989012684A1/en unknown
- 1989-06-23 PT PT90967A patent/PT90967B/pt not_active IP Right Cessation
-
1990
- 1990-12-21 DK DK304390A patent/DK304390A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU623913B2 (en) | 1992-05-28 |
GB2220941B (en) | 1991-09-11 |
EP0353851A1 (en) | 1990-02-07 |
PT90967A (pt) | 1989-12-29 |
GB2220941A (en) | 1990-01-24 |
DE68912441T2 (de) | 1994-05-11 |
GB8914306D0 (en) | 1989-08-09 |
JP2538367B2 (ja) | 1996-09-25 |
DE68912441D1 (de) | 1994-03-03 |
DK304390D0 (da) | 1990-12-21 |
DK304390A (da) | 1990-12-21 |
AU3853789A (en) | 1990-01-12 |
JPH03502524A (ja) | 1991-06-13 |
WO1989012684A1 (en) | 1989-12-28 |
EP0353851B1 (en) | 1994-01-19 |
US5310671A (en) | 1994-05-10 |
PT90967B (pt) | 1993-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061996T3 (es) | Regiones no esenciales de avipoxvirus. | |
ES2664505T3 (es) | Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas | |
MX9202512A (es) | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. | |
ES2140418T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
DE69737058D1 (de) | Rekombinante hunde-herpesviren | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
CY1120856T1 (el) | Μεθοδοι παραδοσης γονιδιων | |
ES2165405T3 (es) | Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv). | |
ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
ES2195998T3 (es) | Sistemas de expresion de dna basados en alfavirus. | |
ES2143507T3 (es) | Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia. | |
ES2301178T3 (es) | Vectores basados en alfavirus recombinantes con inhibicion reducida de la sintesis macromolecular celular. | |
ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
CY1106848T1 (el) | Τροποποιημενος ιος vaccinia ankara για τον εμβολιασμο νεογνων | |
ES2031453T3 (es) | Gene-clonas del virus de la enfermedad de newcastle. | |
ES2056565T3 (es) | Virus recombinante de la enfermedad de marek. | |
AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
PE20210341A1 (es) | Composiciones de virus adeno-asociadas para la transferencia de genes pah y metodos de uso de los mismos | |
CY1106570T1 (el) | Σταθερες, εξασθενημενες μεταλλαγμενες μορφες ιου λυσσας και ζωντανια εμβολια αυτων | |
ES2196032T3 (es) | Mutantes y vacunas del virus de la anemia infecciosa de los pollos y utilizaciones basadas sobre las proteinas virales vp1, vp2 y vp3 o secuencias de dicho virus que las codifican. | |
AR019250A1 (es) | Formas atenuadas del virus de la diarrea viral bovina, molecula de acido nucleico, vector, uso, metodo para modificar el genoma viral de tipo salvaje, genoma modificado, vacuna, metodo para atenuar un virus bvd de tipo salvaje | |
ES2188605T3 (es) | Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina. | |
CO2022004984A2 (es) | Virus del moquillo canino hemaglutinina y polipéptidos de fusión | |
AR035326A1 (es) | Control de la relacion de sexos de la progenie mediante transgenes diana en los cromosomas sexuales | |
ES2061603T3 (es) | Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 353851 Country of ref document: ES |